The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer. [electronic resource]
Producer: 20171215Description: 14279-90 p. digitalISSN:- 1949-2553
- Adenocarcinoma -- drug therapy
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Biomarkers, Tumor
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Proliferation -- drug effects
- Cisplatin -- pharmacology
- Drug Resistance, Neoplasm
- Epithelial-Mesenchymal Transition
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- HSP27 Heat-Shock Proteins -- genetics
- Humans
- Lung Neoplasms -- drug therapy
- Male
- Middle Aged
- Prognosis
- Survival Rate
- Tumor Cells, Cultured
- p38 Mitogen-Activated Protein Kinases -- genetics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.